0000000000056235

AUTHOR

Damian Kawecki

0000-0003-4445-9721

showing 3 related works from this author

Annual Trends in Total Ischemic Time and One-Year Fatalities: The Paradox of STEMI Network Performance Assessment

2019

This study is aimed at assessing trends and relations between total ischemic time, the major quality measure of systemic delay, and case-fatality at the population or patient level in response to growing cardiovascular risk and a constant need to shorten the time to treatment in ST-segment elevation myocardial infarction (STEMI). Data from a prospective nationwide registry of STEMI patients admitted between 2006 and 2013 who were treated with primary percutaneous coronary intervention (PCI) were analyzed. Total ischemic time was calculated as the time from the onset of symptoms to primary PCI and was determined as individual and annual. The primary end-point was one-year, all-cause case-fat…

medicine.medical_specialtyMultivariate analysismedicine.medical_treatmentPopulationlcsh:MedicineIschemic time030204 cardiovascular system & hematologyArticleSTEMI03 medical and health sciencestotal ischemic time0302 clinical medicineInternal medicineCase fatality ratemedicinecase-fatality030212 general & internal medicineMyocardial infarctioncardiovascular diseasesRisk factoreducationeducation.field_of_studybusiness.industrylcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseConventional PCInetworkCardiologybusinessJournal of Clinical Medicine
researchProduct

Real-Life Outcomes of Coronary Bifurcation Stenting in Acute Myocardial Infarction (Zabrze–Opole Registry)

2021

Percutaneous coronary intervention (PCI) of bifurcation lesions is a technical challenge associated with high risk of adverse events, especially in primary PCI. The aim of the study is to analyze long-term outcomes after PCI for coronary bifurcation in acute myocardial infarction (AMI). The outcome was defined as the rate of major adverse cardiac event related to target lesion failure (MACE-TLF) (death-TLF, nonfatal myocardial infarction-TLF and target lesion revascularization (TLR)) and the rate of stent thrombosis (ST). From 306 patients enrolled to the registry, 113 were diagnosed with AMI. In the long term, AMI was not a risk factor for MACE-TLF. The risk of MACE-TLF was dependent on th…

Target lesionmedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionCulpritArticlemedicine.arteryInternal medicinemedicineDiseases of the circulatory (Cardiovascular) systemPharmacology (medical)cardiovascular diseasesMyocardial infarctionGeneral Pharmacology Toxicology and PharmaceuticsRisk factoracute myocardial infarction; coronary bifurcation; percutaneous coronary intervention; target lesion failureAdverse effectcoronary bifurcationbusiness.industrypercutaneous coronary interventionPercutaneous coronary interventionmedicine.diseaseRC666-701Right coronary arteryConventional PCICardiologytarget lesion failurebusinessJournal of Cardiovascular Development and Disease
researchProduct

P2711Place of residence and its impact on time to invasive treatment and outcomes of patients with STEMI - analysis from the PL-ACS and AMI-PL regist…

2018

medicine.medical_specialtybusiness.industryEmergency medicineMedicineResidenceCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct